{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:55:33Z","timestamp":1791266133825,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cell.2018.03.021","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T11:40:42Z","timestamp":1521718842000},"page":"5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Gene Therapy for Retinal Degeneration"],"prefix":"10.1016","volume":"173","author":[{"given":"Rajendra S.","family":"Apte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2018.03.021_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13816810490514261","article-title":"Leber congenital amaurosis: a genetic paradigm","volume":"25","author":"Allikmets","year":"2004","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.cell.2018.03.021_bib2","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives","author":"Dias","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.cell.2018.03.021_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2018.03.021_bib4","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1016\/S0021-9258(18)82319-5","article-title":"Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro","volume":"268","author":"Hamel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2018.03.021_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2005.06.042","article-title":"Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium","volume":"122","author":"Jin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.03.021_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ng1097-139","article-title":"Mutations in RPE65 cause Leber\u2019s congenital amaurosis","volume":"17","author":"Marlhens","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2018.03.021_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2018.03.021_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K","article-title":"Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies","volume":"17","author":"Sohocki","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cell.2018.03.021_bib9","unstructured":"Food and Drug Administration. 2017 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee. https:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/CellularTissueandGeneTherapiesAdvisoryCommittee\/ucm574396.htm"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418303015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418303015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:31:23Z","timestamp":1758799883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867418303015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0092867418303015"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2018.03.021","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Therapy for Retinal Degeneration","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2018.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}